Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Homatropine methylbromide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine methylbromide 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine methylbromide + hydrocodone bitartrate 1.5mg/5mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine methylbromide + hydrocodone bitartrate 1.5mg/5mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine methylbromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing homatropine methylbromide and hydrocodone bitartrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 2% preservative-free eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 0.125% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 0.25% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 0.5% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 1% preservative-free eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 2% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 20 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely homatropine hydrobromide 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine hydrobromide 5% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Homatropine methylbromide 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Homatropine methylbromide 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Homatropine methylbromide 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Homatropine methylbromide 10 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Homatropine methylbromide 5 mg oral tablet |
Has precise active ingredient |
True |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Homatropine methylbromide 10 mg oral tablet |
Has precise active ingredient |
True |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet |
Has precise active ingredient |
True |
Homatropine methylbromide |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |